- Home
- LGO vs GALT Comparison
LGO vs GALT Comparison
Compare LGO & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- GALT
- Stock Information
- Founded
- LGO 1988
- GALT 2000
- Country
- LGO Canada
- GALT United States
- Employees
- LGO N/A
- GALT N/A
- Industry
- LGO
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- GALT Health Care
- Exchange
- LGO Nasdaq
- GALT Nasdaq
- Market Cap
- LGO 134.0M
- GALT 147.8M
- IPO Year
- LGO 2007
- GALT N/A
- Fundamental
- Price
- LGO $1.70
- GALT $1.04
- Analyst Decision
- LGO Strong Buy
- GALT Strong Buy
- Analyst Count
- LGO 1
- GALT 1
- Target Price
- LGO $4.20
- GALT $11.00
- AVG Volume (30 Days)
- LGO 143.9K
- GALT 1.1M
- Earning Date
- LGO 11-12-2024
- GALT 11-13-2024
- Dividend Yield
- LGO N/A
- GALT N/A
- EPS Growth
- LGO N/A
- GALT N/A
- EPS
- LGO N/A
- GALT N/A
- Revenue
- LGO $144,822,000.00
- GALT N/A
- Revenue This Year
- LGO N/A
- GALT N/A
- Revenue Next Year
- LGO $37.73
- GALT N/A
- P/E Ratio
- LGO N/A
- GALT N/A
- Revenue Growth
- LGO N/A
- GALT N/A
- 52 Week Low
- LGO $1.38
- GALT $0.73
- 52 Week High
- LGO $2.84
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- LGO 34.97
- GALT 20.80
- Support Level
- LGO $2.03
- GALT $1.80
- Resistance Level
- LGO $1.84
- GALT $2.36
- Average True Range (ATR)
- LGO 0.12
- GALT 0.27
- MACD
- LGO -0.04
- GALT -0.08
- Stochastic Oscillator
- LGO 9.30
- GALT 15.07
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.